{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:20:56Z","timestamp":1780500056395,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.radonc.2024.110460","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:44:01Z","timestamp":1722044641000},"page":"110460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-8576","authenticated-orcid":false,"given":"Amanda","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke N.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-5263","authenticated-orcid":false,"given":"Rebecca","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McNair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-4703","authenticated-orcid":false,"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5999-5020","authenticated-orcid":false,"given":"Emma","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Huddart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110460_b0005","unstructured":"RTTQA. About RTTQA RTTQA Group Vision Statement. 2023 [cited 2023 26\/06\/2023]; Available from: https:\/\/rttrialsqa.org.uk\/?page_id=14."},{"key":"10.1016\/j.radonc.2024.110460_b0010","unstructured":"EORTC. RADIOTHERAPY RTQA. 2022; Available from: https:\/\/www.eortc.org\/quality-assurance\/rtqa\/."},{"key":"10.1016\/j.radonc.2024.110460_b0015","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1200\/JCO.2001.19.11.2905","article-title":"Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin\u2019s Disease: Long-Term Results of a Randomized Trial of Radiotherapy Alone","volume":"19","author":"Duhmke","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0020","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2009.21.8529","article-title":"Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411","volume":"27","author":"Crane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0025","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0035","doi-asserted-by":"crossref","first-page":"20120398","DOI":"10.1259\/bjr.20120398","article-title":"Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case","volume":"86","author":"Gwynne","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2024.110460_b0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2024.110460_b0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13014-017-0916-7","article-title":"Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy","volume":"12","author":"Wills","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0050","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3389\/fonc.2019.00792","article-title":"The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment","volume":"9","author":"Zhong","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phro.2021.10.003","article-title":"Quality assurance of dysphagia-optimised intensity modulated radiotherapy treatment planning for head and neck cancer","volume":"20","author":"Tyler","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109494","article-title":"Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison","volume":"182","author":"Taylor","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0065","unstructured":"Radiologists, T.R.C.o., On target 2: updated guidance for image-guided radiotherapy. 2021."},{"key":"10.1016\/j.radonc.2024.110460_b0070","doi-asserted-by":"crossref","first-page":"e041005","DOI":"10.1136\/bmjopen-2020-041005","article-title":"Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance","volume":"10","author":"Hafeez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2024.110460_b0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2021.02.009","article-title":"The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance","volume":"33","author":"Webster","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2024.110460_b0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tipsro.2022.01.002","article-title":"Recognising the challenges of implementing multi-centre adaptive plan of the day radiotherapy","volume":"21","author":"Webster","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110460_b0085","doi-asserted-by":"crossref","first-page":"20140690","DOI":"10.1259\/bjr.20140690","article-title":"Radiographer-led plan selection for bladder cancer radiotherapy: initiating a training programme and maintaining competency","volume":"88","author":"McNair","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2024.110460_b0090","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.radi.2023.05.015","article-title":"What do we want? Training! When do we want it? Now? A training needs analysis for adaptive radiotherapy for therapeutic radiographers","volume":"29","author":"Joyce","year":"2023","journal-title":"Radiography"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024007308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024007308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T05:49:00Z","timestamp":1729057740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024007308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":18,"alternative-id":["S0167814024007308"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110460","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110460"}}